Bradmer Pharmaceuticals Inc. (TSE:GLX) Given Average Recommendation of “Buy” by Brokerages

Bradmer Pharmaceuticals Inc. (TSE:GLX) has received an average rating of “Buy” from the six analysts that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating, one has assigned a buy rating and three have issued a strong buy rating on the company.

A number of equities analysts have recently issued reports on GLX shares. Citigroup upgraded shares of Bradmer Pharmaceuticals to a “hold” rating in a research report on Tuesday, February 24th. ATB Cormark Capital Markets downgraded shares of Bradmer Pharmaceuticals from a “strong-buy” rating to a “moderate buy” rating in a research report on Thursday, February 5th.

Bradmer Pharmaceuticals Price Performance